Syndecans in hematopoietic cells and their niches
American Journal of Physiology-Cell Physiology · 01.08.2024 · 327 (2) · C372-C378
DOI: 10.1152/ajpcell.00326.2024 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift American Journal of Physiology-Cell Physiology, erschienen am 01.08.2024. Verfasst von Matthew W Hagen und 3 weiteren Autor:innen. Beteiligte Einrichtung: Translational Science & Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States. Hauptthemen laut MEDLINE: Hematopoietic Stem Cells, Stem Cell Niche, Syndecans. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, American Heart Association (AHA), Andy Hill Cancer Research Endowment Fund.
Abstract (Originalsprache)
Heparan sulfate proteoglycans are a family of glycoproteins that modulate cell signaling by binding growth factors and changing their bioavailability. Syndecans are a specific family of transmembrane heparan sulfate proteoglycans that regulate cell adhesion, migration, and signaling. In this review, we will summarize emerging evidence for the functions of syndecans in the normal and malignant blood systems and their microenvironments. More specifically, we detail the known functions of syndecans within normal hematopoietic stem cells. Furthermore, we discuss the functions of syndecans in hematological malignancies, including myeloid malignancies, lymphomas, and bleeding disorders. As normal and malignant hematopoietic cells require cues from their microenvironments to function, we also summarize the roles of syndecans in cells of the stromal, endothelial, and osteolineage compartments. Syndecan biology is a rapidly evolving field; a comprehensive understanding of these molecules and their place in the hematopoietic system promises to improve our grasp on disease processes and better predict the efficacies of growth factor-targeting therapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Translational Science & Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States.
- Human Biology Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States.
- Department of Laboratory Medicine and Pathology, University of Washington School of Medicine, Seattle, Washington, United States.
ORCID-Profile: Matthew W Hagen, Christina M Termini
Förderung
- NIDDK NIH HHS
- American Heart Association (AHA)
- Andy Hill Cancer Research Endowment Fund
- HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Zitieren
APA
Hagen, M. W., Setiawan, N. J., Woodruff, K. A., & Termini, C. M. (2024). Syndecans in hematopoietic cells and their niches. American Journal of Physiology-Cell Physiology, 327(2), C372-C378. https://doi.org/10.1152/ajpcell.00326.2024
Vancouver
Hagen MW, Setiawan NJ, Woodruff KA, Termini CM. Syndecans in hematopoietic cells and their niches. American Journal of Physiology-Cell Physiology. 2024;327(2):C372-C378. doi:10.1152/ajpcell.00326.2024
BibTeX
@article{Hagen2024,
author = {Hagen, Matthew W and Setiawan, Nicollette J and Woodruff, Kelsey A and Termini, Christina M},
title = {Syndecans in hematopoietic cells and their niches},
journal = {American Journal of Physiology-Cell Physiology},
year = {2024},
volume = {327},
number = {2},
pages = {C372--C378},
doi = {10.1152/ajpcell.00326.2024}
}
EUVIMED